you are here: HomeNewsCovishield
covishield
Jump to
162 Results Found
  • Bleeding and clotting events following COVID-19 vaccination 'miniscule', says govt panel May 17, 2021 03:25 PM IST

    Bleeding and clotting events following COVID-19 vaccination 'miniscule', says govt panel

    The National AEFI Committee found that till April 3, 26 incidents of potential thromboembolic cases (blood clotting) following the administration of the Covishield vaccine were reported in India, with a reporting rate of 0.61 cases/ million doses.

  • Already booked online appointments for 2nd Covishield dose to remain valid: Govt May 16, 2021 10:51 PM IST

    Already booked online appointments for 2nd Covishield dose to remain valid: Govt

    The Centre had on May 13 extended the gap between the first and second doses of Covishield vaccine to 12-16 weeks based on the recommendations by the COVID Working Group chaired by N K Arora.

  • Govt reconfigures CoWIN to reflect change in Covishield vaccine dose interval of 12-16 weeks May 16, 2021 06:57 PM IST

    Govt reconfigures CoWIN to reflect change in Covishield vaccine dose interval of 12-16 weeks

    The two jabs of the Serum Institute of India (SII)-manufactured Covishield vaccine were earlier administered at a gap of six-to-eight weeks.

  • Has Covishield dose interval extended due to vaccine crunch? 'Saddened' by such allegations, says Dr VK Paul May 15, 2021 05:19 PM IST

    Has Covishield dose interval extended due to vaccine crunch? 'Saddened' by such allegations, says Dr VK Paul

    Dr VK Paul's response to the controversy comes two days after the Centre, based on an expert panel's recommendation, increased the gap between two doses of Covishield vaccine from 6-8 weeks to 12-16 weeks.

  • Centre to supply over 19 million doses of COVID-19 vaccines to states, UTs for free May 14, 2021 01:23 PM IST

    Centre to supply over 19 million doses of COVID-19 vaccines to states, UTs for free

    During 16-31 May, 191.99 lakh doses of Covishield and Covaxin will be supplied to the States and UTs, free of cost.

  • Herd Immunity Part 2: Is the race a sprint or a marathon? May 14, 2021 12:10 PM IST

    Herd Immunity Part 2: Is the race a sprint or a marathon?

    In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.

  • India should work with other countries to boost COVID-19 vaccine availability: Dr Anthony Fauci May 14, 2021 10:34 AM IST

    India should work with other countries to boost COVID-19 vaccine availability: Dr Anthony Fauci

    On India's decision to extend the gap between two Covishield doses, Dr Anthony Fauci said that it is a "reasonable approach".

  • Coronavirus India News Highlights: COVID pandemic to be 'far more deadly' this year, WHO warns May 14, 2021 07:53 AM IST

    Coronavirus India News Highlights: COVID pandemic to be 'far more deadly' this year, WHO warns

    Coronavirus India News Highlights: The cumulative number of COVID-19 vaccine doses administered inched closer to 18 crore, the Union Health Ministry said.

  • As vaccines become scarce, states adopt different strategies to secure supplies May 13, 2021 06:22 PM IST

    As vaccines become scarce, states adopt different strategies to secure supplies

    While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.

  • More than 2 billion doses of COVID-19 vaccines to become available: Govt May 13, 2021 05:55 PM IST

    More than 2 billion doses of COVID-19 vaccines to become available: Govt

    Around 750 million doses of Covishield and 550 million doses of Covaxin would be available in the period between August and December, said Niti Aayog member Dr VK Paul.

  • COVID-19 Vaccine | Gap between two Covishield doses extended to 12-16 weeks: Union Health Ministry May 13, 2021 04:44 PM IST

    COVID-19 Vaccine | Gap between two Covishield doses extended to 12-16 weeks: Union Health Ministry

    The suggestion to increase the gap between two Covishield doses was made by the National Technical Advisory Group on Immunisation (NTAGI).

  • NTAGI suggests increasing dosage interval of Covishield to 12-16 weeks May 13, 2021 12:09 PM IST

    NTAGI suggests increasing dosage interval of Covishield to 12-16 weeks

    Currently, India is facing an acute nationwide shortage of the Covishield vaccine and Serum Institute is struggling to keep up with demand.

  • Maharashtra COVID-19 vaccination for 18-44 age group to resume after SII sends 1.5 crore Covishield doses May 12, 2021 08:15 PM IST

    Maharashtra COVID-19 vaccination for 18-44 age group to resume after SII sends 1.5 crore Covishield doses

    Maharashtra Health Minister Rajesh Tope has said COVID-19 vaccination for the 18-44 age group has been suspended temporarily due to vaccine shortage.

  • Where to get the cheapest jab for COVID-19 across metro cities: Check here May 11, 2021 04:52 PM IST

    Where to get the cheapest jab for COVID-19 across metro cities: Check here

    The cheapest option among all metro cities to get the jab at a private setup is at HN Reliance Hospital where you can get a dose of Covishield for Rs 700.

  • Kerala receives 3.5 lakh doses of Covishield May 10, 2021 01:15 PM IST

    Kerala receives 3.5 lakh doses of Covishield

    An Indigo regular flight carrying the Covishield vaccine landed at Cochin International Airport at 11.50 AM, a CIAL spokesman said.

  • COVID-19: Madras HC calls for revival of government-owned vaccine institutes May 09, 2021 03:44 PM IST

    COVID-19: Madras HC calls for revival of government-owned vaccine institutes

    Covaxin is developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology

  • COVID-19 | Second or third generation versions of Indian variant may be more dangerous, says expert May 06, 2021 05:46 PM IST

    COVID-19 | Second or third generation versions of Indian variant may be more dangerous, says expert

    The new observations which Prof Haseltine pointed out have more chances to be correct as the new variants of COVID-19 may be currently racing through India’s tightly-packed population of 1.4 billion people.

  • COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered May 06, 2021 11:27 AM IST

    COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered

    What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.

  • Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts May 05, 2021 12:43 PM IST

    Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

    Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

  • Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report May 05, 2021 10:24 AM IST

    Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report

    In September 2020, the Bill and Melinda Gates Foundation provided $150 million to the Pune-based vaccine-maker to fund the additional 10 crore COVID-19 vaccine doses.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Full advance of over Rs 1,700 crore released to SII for 11 crore doses of Covishield on April 28: Govt May 03, 2021 03:25 PM IST

    Full advance of over Rs 1,700 crore released to SII for 11 crore doses of Covishield on April 28: Govt

    As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are "incorrect and not based on facts".

  • COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla May 03, 2021 02:11 PM IST

    COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla

    The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."

  • COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla May 02, 2021 08:32 AM IST

    COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla

    Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.

  • Serum Institute plans to start vaccine production outside India May 01, 2021 10:42 AM IST

    Serum Institute plans to start vaccine production outside India

    Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May.

Sections